SkyePharma Plc said that bondholders have approved a major debt refinancing that will lighten its short-term liquidity commitments. Separately, the company confirmed that it is due €4 million following the launch of flutiform in Germany. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
